TrialBMJ open2022

Assessment of global coagulation function under treatment with emicizumab concomitantly with bypassing agents in haemophilia A with inhibitor (UNEBI Study): multicentre open-label non-randomised clinical trial.

Kenichi Ogiwara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.